RecruitingNCT04425434

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma


Sponsor

French Africa Pediatric Oncology Group

Enrollment

3,000 participants

Start Date

Nov 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying OBSERVATIONAL for people with retinoblastoma. The study is currently recruiting participants at 7 locations. People eligible for this study include up to age 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROBSERVATIONAL

We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.


Locations(7)

Hopital Yalgado Ouedraogo

Ouagadougou, Burkina Faso

CHU de Treichville à ABIDJAN

Abidjan, Côte d’Ivoire

CUK (Cliniques Universitaires de Kinshasa)

Kinshasa, Kinshasa City, Democratic Republic of the Congo

Cliniques Universitaires de Lubumbashi (CUL)

Lubumbashi, Democratic Republic of the Congo

HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona

Antananarivo, Ampefiloha, Madagascar

CHU Gabriel Touré (HGT)

Bamako, Mali

Hôpital Aristide Le Dantec,

Dakar, Senegal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04425434


Related Trials